Guangdong Taienkang Pharmaceutical Co., Ltd. (SHE:301263)

China flag China · Delayed Price · Currency is CNY
21.96
+0.86 (4.08%)
At close: Jul 3, 2026
Market Cap11.16B -15.0%
Revenue (ttm)679.75M -5.1%
Net Income25.67M -72.8%
EPS0.05 -70.9%
Shares Out 508.22M
PE Ratio434.77
Forward PEn/a
Dividend0.04 (0.19%)
Ex-Dividend DateJun 1, 2026
Volume10,621,124
Open21.09
Previous Close21.10
Day's Range21.09 - 22.08
52-Week Range17.52 - 35.22
Beta0.29
Analystsn/a
Price Targetn/a
Earnings DateAug 18, 2026

About SHE:301263

Guangdong Taienkang Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in China and internationally. The company offers various products covering various therapeutic areas, including sexual health medicines, ophthalmic medicines, gastrointestinal medicines, Chinese patent medicines and external medicines, and sanitary materials in the form of tablets, pills, injections, and essential oils; medical technology and technology transfer services; and medical devices. It also operates as ... [Read more]

Sector Healthcare
Founded 1999
Employees 1,154
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301263
Full Company Profile

Financial Performance

In 2025, SHE:301263's revenue was 674.90 million, a decrease of -6.40% compared to the previous year's 721.03 million. Earnings were 28.63 million, a decrease of -73.54%.

Financial Statements